http://orcid.org/0000-0001-6581-242X
Figures
Abstract
Background
Influenza is an important contributor to acute respiratory illness, including pneumonia, and results in substantial morbidity and mortality globally. Understanding the local burden of influenza-associated severe disease can inform decisions on allocation of resources toward influenza control programs. Currently, there is no national influenza vaccination program in Uganda.
Methods
In this study, we used data on pneumonia hospitalizations that were collected and reported through the Health Management Information System (HMIS) of the Ministry of Health, Uganda, and the laboratory-confirmed influenza positivity data from severe acute respiratory illness (SARI) surveillance in three districts (Wakiso, Mbarara, and Tororo) to estimate the age-specific incidence of influenza-associated pneumonia hospitalizations from January 2013 through December 2016.
Results
The overall estimated mean annual rate of pneumonia hospitalizations in the three districts was 371 (95% confidence interval [CI] 323–434) per 100,000 persons, and was highest among children aged <5 years (1,524 [95% CI 1,286–1,849]) compared to persons aged ≥5 years (123 [95% CI 105–144]) per 100,000 persons. The estimated mean annual rate of influenza-associated pneumonia hospitalization was 34 (95% CI 23–48) per 100,000 persons (116 [95% CI 78–165] and 16 [95% CI 6–28] per 100,000 persons among children aged <5 years and those ≥5 years, respectively). Among children aged <5 years, the rate of hospitalized influenza-associated pneumonia was highest among those who were <2 years old (178 [95% CI 109–265] per 100,000 persons). Over the period of analysis, the estimated mean annual number of hospitalized influenza-associated pneumonia cases in the three districts ranged between 672 and 1,436, of which over 70% represent children aged <5 years.
Citation: Emukule GO, Namagambo B, Owor N, Bakamutumaho B, Kayiwa JT, Namulondo J, et al. (2019) Influenza-associated pneumonia hospitalizations in Uganda, 2013-2016. PLoS ONE 14(7): e0219012. https://doi.org/10.1371/journal.pone.0219012
Editor: Ray Borrow, Public Health England, UNITED KINGDOM
Received: February 7, 2019; Accepted: June 13, 2019; Published: July 15, 2019
This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Data Availability: All relevant data are within the manuscript and its Supporting Information files. However, should there be need for additional data, a request can be made directly to Dr. Julius Lutwama (Program Coordinator, and Head of the Department of Arbovirology and Emerging Viral Infections at Uganda Virus Research Institute, Uganda; Email: jjlutwama03@yahoo.com).
Funding: This study was supported by U.S. Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Background
Influenza viruses are important contributors to lower respiratory tract infections (LRTI), such as pneumonia, resulting in substantial morbidity and mortality globally every year [1–3]. In general, children aged <2 years, pregnant women, persons with underlying medical conditions, and the elderly are at increased risk of severe disease [4, 5]. In tropical sub-Saharan Africa, other risk factors for influenza severity include human immuno-deficiency virus/acquired immune deficiency syndrome (HIV/AIDS), tuberculosis (TB), malaria, and malnutrition [6–9]. Studies conducted in African countries have estimated rates of influenza-associated hospitalizations that are more than 2-fold higher than estimates from the USA and other industrialized countries [10–14].
In Uganda, the current influenza surveillance system was established in 2006, initially for influenza-like illness (ILI) surveillance. In 2011, severe acute respiratory illness (SARI) surveillance started, partly in response to the global emerging threat of avian and pandemic influenza [15]. As with other tropical and sub-tropical countries [16–18], influenza viruses circulate in Uganda throughout the year with two major peaks and its epidemiology has recently been described [15, 19–21]. However, the burden of influenza-associated pneumonia in Uganda is yet to be reported. Disease burden data are important to inform policy and resources allocation towards influenza control programs as currently there is no national influenza vaccination program in Uganda.
In this study, we used data on pneumonia hospitalizations collected and reported through the Uganda Ministry of Health’s Health Management Information System (HMIS), and the laboratory-confirmed influenza detection data collected from SARI surveillance in three districts (Wakiso, Mbarara, and Tororo) to estimate age-specific incidence of influenza-associated pneumonia hospitalizations from January 2013 through December 2016.
Methods
Study sites and population
SARI surveillance was established in Entebbe General Hospital (EGH), Mbarara Regional Referral Hospital (MRH), and Tororo General Hospital (TGH) (See Fig 1) in 2011; consistent data were available beginning January 2013. These are the main referral hospitals for residents of Wakiso, Mbarara and Tororo districts respectively. Wakiso is a district in the Central Region of Uganda that partly encircles Kampala, Uganda's capital city. As per the 2014 census, Wakiso district had a population of 1,997,418, with a majority of them (60%) living in urban settlements [22]. Mbarara district is in the Southwestern region of Uganda, and had an estimated population of 472,629 in 2014, of which 60% lived in rural settlements. Tororo district is located in the Eastern part of Uganda and had an estimated population of 517,082 in 2014, of which 86% were living in rural settlements [22]. The total population from these three districts represents 9% of the Ugandan population based on the 2014 census.
Description of the Uganda Ministry of Health’s Health Management Information System
The Uganda HMIS is an integrated reporting system used by the Ministry of Health (MoH), and other stakeholders to collect information to enable planning, decision making, and monitoring and evaluation of the health care delivery system [23]. The HMIS collects information on a routine basis from every public health unit in all districts within Uganda. Through sets of data collection tools, patient-level data are captured, aggregated into summary reports and submitted first to the district-level unit, and subsequently transmitted to the national-level office. Among the health indicators reported through this system are the service delivery statistics, maternal deaths, and outpatient and inpatient diagnoses (including pneumonia cases as diagnosed by the attending clinician on hospital visit or admission).
Aggregate pneumonia hospitalization data (by sex and age: <5 years, and ≥5 years) are reported from all public and religious-based health facilities on a monthly basis. These monthly summary reports are generated by tallying cases recorded in the hard-copy hospital admission registers at the respective health facilities by the responsible personnel (nurses and health records management staff). These summaries are then entered into an Excel-based template, which is sent by email to the district-level office. Sites that did not have access to computers filled the monthly report summaries on a hard-copy report templates which are then sent to the district-level office for further processing and onward transmission to the national office.
SARI surveillance and testing for influenza
At each of three hospitals, surveillance officers enrolled patients of all ages who were hospitalized with SARI. The case definition used for SARI enrollment was based on hospitalization for an acute onset of illness (within the last 14 days) with age specific clinical inclusion criteria. For children <5 years old, a modified version of the World Health Organization’s Integrated Management of Childhood Illness (IMCI) definition for pneumonia was used, requiring the presence of cough or difficulty breathing and one or more of the following danger signs: chest in-drawing, stridor, unable to breastfeed or drink, vomits everything, convulsions, lethargy, or unconsciousness [24]. For patients aged ≥5 years, SARI was defined as axillary temperature ≥38°C or history of fever, plus cough or difficulty breathing or shortness of breath.
Patients who were enrolled provided a verbal consent and had nasopharyngeal (NP) and/or oropharyngeal (OP) swabs collected. A structured questionnaire was filled by medical chart abstraction and through direct interview with the patient or caretaker. The NP/OP swabs were combined into a single viral transport media, and sent to the Uganda Virus Research Institute—National Influenza Centre (UVRI-NIC) laboratory in Entebbe where they were tested for influenza A and B by real-time reverse transcription polymerase chain reaction (rtRT-PCR) as previously described [15, 19]. Specimen that tested positive for influenza A were subjected to further testing for subtype characterization at the same laboratory.
Dealing with gaps, incompleteness, and inconsistency in reporting pneumonia data
Three approaches were applied to correct the data on completeness and inconsistencies in reporting as outlined in Fig 2. To adjust for completeness, we adjusted for gaps in each health facility’s monthly reporting using data from facilities, within the same district, with complete data. The district-level monthly distribution of pneumonia was calculated using data from health facilities that had submitted reports for every month in a particular year (100% reporting). For example, consider that data were missing for the months of July, August and September in facility X. If we determined from the district-level data (for the hospitals that had 100% reporting) that the months of July to September contributed 40% of the annual total, the annual total number of pneumonia cases in facility X (adjusted for missing data) will be calculated as sum of cases for the months when data were reported divided by 0.6 (1.0–0.4).
As a second step, to address potential inconsistencies in reporting, a data validation exercise was conducted in a randomly selected number of health facilities. These included the general hospital (where influenza surveillance is ongoing), two other hospitals, and two health centers in each of the three districts. This assessment involved visiting the selected health facilities and conducting a record review of the admission registers to re-tally the number of pneumonia cases that were recorded over a two-year period aggregated by sex and age (<5 years and ≥5 years) as is typically done for HMIS reporting. These re-tallied data were then compared to what was reported to HMIS. An adjustment factor (to correct for potential over/under reporting) was calculated as the reciprocal of the fraction of the total number of pneumonia cases that were reported through HMIS compared to the total number of cases tallied during the data validation.
A third and final step involved adjusting for proportion of pneumonia cases that sought healthcare at private facilities and thus were not necessarily captured through the HMIS (Fig 2). This was done using the proportion of those who reported to seek healthcare (any care seeking) at a public health facility as reported in the healthcare utilization survey that was conducted in 2014 [25]. The adjustment factors used in steps 2 and 3 to estimate the total number of hospitalized pneumonia cases are shown in Table 1.
Calculating rates of pneumonia and influenza-associated pneumonia
For each of the three districts selected for this analysis, the estimated number of hospitalized pneumonia cases (incorporating the adjustments outlined above) were calculated. Age-specific (<2, 2–4, 5–14, 15–49, 50–64, and ≥65 years) rates of hospitalized pneumonia were calculated by dividing the number of estimated pneumonia cases by the annual age-specific population [22]. Population estimates for 2013, 2015, and 2016 were projected from 2014 census while assuming an annual population growth rate of 3% [22]. Although pneumonia data reported through HMIS were only available in two broad age categories (<5, and ≥5 years), we assumed that hospitalized patients reported through HMIS had the same age distribution as the SARI cases identified from the influenza surveillance (at the three sites) and applied it to obtain age-specific cases of pneumonia in the finer age categories as defined above. The distribution of SARI cases among patients who were aged ≥13 years were similar to what was published in Kenya for patients who were hospitalized with a respiratory illness [26].
To estimate the age-specific rate of influenza-associated pneumonia hospitalizations, the age-specific (<2, 2–4, and ≥5 years) and annual proportion of SARI cases that tested positive for influenza (Fig A in S2 File) was applied to rate of pneumonia hospitalizations. As influenza testing data were limited, SARI data collected from the three sites (EGH, MRH and TGH) were combined and used to estimate the fraction of SARI cases with influenza. The number of hospitalized influenza-associated pneumonia cases was estimated by applying the estimated age-specific rate of influenza-associated hospitalizations to the age-specific population.
Data analyses
All data analyses were performed using Stata version 13.0 (StataCorp. 2013. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP). Confidence intervals (CIs) for the rates were estimated by running 1,000 iterations for the respective age categories and each time allowing all of the adjustment factors (for under/over reporting and healthcare utilization), and the proportion of SARI cases that tested positive for influenza to randomly vary within a given range. For each iteration, the parameters were assumed to follow a binomial distribution and centered on the mean. The lower and upper limits of the 95% CI were the 2.5th and 97.5th percentiles of the estimated values obtained from the 1,000 iterations, respectively. All rates were reported per 100,000 persons.
Ethical considerations
The Ugandan Ministry of Health considered influenza surveillance, and data collected and reported through the HMIS as a routine public health activity and therefore did not require a formal ethical review. SARI data were anonymized upon collection, and authors did not have access to identifying information. Similarly, pneumonia data that were reported through HMIS were anonymized and only available in aggregate form.
Results
Descriptive analyses
From 2013 through 2016, a total of 2,662 SARI cases were enrolled at the three SARI surveillance hospitals (EGH = 660, MRH = 675, and TGH = 1,327). Of the SARI cases enrolled, 90% were children aged <5 years, and 201 (7.6%) tested positive for influenza (<2 years = 6.1%; 2–4 years = 10.5%; ≥5 years = 12.0%).
Of the influenza positive cases identified during this period from these three surveillance sites, 76/201(38%) were influenza A(H3N2), 74/201 (37%) were influenza A(H1N1)pdm09, and 52/201 (26%) were influenza B. A one-year old child was co-infected with influenza A(H3N2) and A(H1N1)pdm09 in 2014. Influenza B was the most commonly circulating type in 2013 (81%), with the influenza A(H1N1)pdm09 dominant in 2014 (63%). Influenza A(H3N2) was the most commonly circulating sub-type in both 2015 (49%) and 2016 (57%) Fig 3 and Table 2.
Rates of hospitalized pneumonia
The mean annual rate of hospitalized pneumonia in the three districts was 371 (95% CI 323–434) per 100,000 persons. Rates in children aged <5 years (1,524 [95% CI 1,286–1,849] per 100,000 persons) were higher than in those aged ≥5 years (123 [95% CI 105–144] per 100,000 persons) (Table 3). The estimated mean annual rates of hospitalized pneumonia were highest in Tororo district (647 [95% CI 595–715] per 100, 000 persons) and lowest in Wakiso district (267 [95% CI 223–329] per 100,000 persons) (Table 3 and Table B in S1 File).
Annual rates of pneumonia hospitalizations varied by year and were highest in 2013 (461 [95% CI 401–538] per 100,000 persons). However, the rates were lowest in the last two years but were comparatively similar (329 [95% CI 287–384] in 2015; and 328 [95% CI 284–384] per 100,000 persons in 2016) (Table B in S1 File).
Rates of hospitalized influenza-associated pneumonia
For the three districts, the mean annual rate of hospitalized influenza-associated pneumonia was 34 (95% CI 23–45) per 100,000 persons (Table 4). The rates were 7-fold higher in children aged < 5 years (116 [95% CI 78–165] per 100,000 persons) compared to persons aged ≥5 years (16 [95% CI 6–28] per 100,000 persons). Among children aged <5 years, the rates were more than 2-fold higher for children aged <2 years (178 [95% CI 109–265] per 100,000 persons) compared to those who were aged 2–4 years (75 [95% CI 37–125] per 100,000 persons).
As was the case with pneumonia, the rates of hospitalized influenza-associated pneumonia were highest in Tororo district (61 [95% CI 40–86] per 100,000 persons) and were lowest in Wakiso district (24 [95% CI 16–34] per 100,000 persons). Overall, the annual rates of hospitalized influenza-associated pneumonia were highest in 2015 (41 [95% CI 26–60] per 100,000 persons) and 2014 (35 [95% CI 25–46] per 100,000 persons), but lowest in 2016 (28 [95% CI 18–38], per 100,000 persons) (Table C in S1 File).
Estimates of hospitalized pneumonia and influenza-associated pneumonia cases
Over the period of analysis, the mean annual number of hospitalized pneumonia cases in the three districts ranged between 9,774 and 13,159 (Table 3). Because of its relatively large population, Wakiso district had the greatest number of cases, ranging from 4,508–6,659 annually. Mbarara and Tororo districts had estimated annual cases of hospitalized pneumonia that ranged between 2,147–2,749, and 3,120–3,753, respectively.
For the three districts, the mean annual number of hospitalized influenza-associated pneumonia cases ranged between 672 and 1,436 (with 414–884 of these among children <5 years). Estimates ranged from 321–673 in Wakiso district, 144–317 in Mbarara, and 207–447 in Tororo district (Table 4).
Discussion
Using data from three districts studied, we found that influenza virus infections resulted in substantial annual rates of pneumonia hospitalization in Uganda, ranging from 28–41 per 100,000 persons. Rates were particularly high among children <2 years with annual hospitalization rates that ranged from 141–232 per 100,000 children. From a total population of 2,987,129 (who were residents of the three districts), and representing 9% of the overall population of Uganda [22], we estimated that there were 672–1,436 hospitalized influenza-associated pneumonia patients annually. Assuming that these three districts were representative of the general population of Uganda, at a national level—estimated at 34,634,650 in 2014 [22], this would translate to an annual estimate of 7,814–16,698 influenza-associated pneumonia hospitalizations, of which over 70% are children <5 years.
The estimates of hospitalized pneumonia and influenza-associated hospitalized pneumonia that we report here varied by district and by year. Overall, the mean annual rates were the highest in Tororo district (hospitalization rates per 100,000 persons for pneumonia was 595–715, and for influenza-associated pneumonia was 40–86) and lowest in Wakiso district (hospitalization rates per 100,000 persons for pneumonia was 223–329, and for influenza-associated pneumonia was 16–34). Geographical differences in the intensity of influenza viruses circulation and varied care seeking behavior or access to care can explain the difference in rates by area and have been described elsewhere [27]. These differences could also be partly explained by differences in demographic characteristics. Tororo district, for example, has a relatively large rural population compared to Wakiso (86% vs. 40%) and comparatively low health indicators such as high prevalence of malnutrition, which has been shown to be risk factor for pneumonia [6]. The rates of influenza-associated pneumonia hospitalizations were highest in 2015 (41 per 100,000 persons) and lowest in 2013 and 2016. These corresponded to the periods when seasonal influenza A(H3N2) and influenza B were circulating in relatively high proportions compared to the other studied years.
The estimates of influenza-associated pneumonia hospitalizations presented here are comparable to those reported in a global systematic review [28], and analysis of influenza-associated SARI hospitalizations in Africa [11–13, 27]. The rates of influenza-associated pneumonia hospitalizations that we estimated among young children aged <5 years were more than 2-fold higher than rates reported in the US and other industrialized countries [28–32]. On the other hand, our estimates (9–41/100,000 persons) for influenza-associated pneumonia hospitalizations among the elderly (≥65 years) were much lower than rates of influenza-associated hospitalizations reported in the US (186–1100/100,000 person-years) [29, 30]. These low estimates among elderly persons in Uganda could be due to low healthcare seeking behaviors as has previously been suggested in studies that were conducted in other African countries of similar settings [10, 11]. Although direct comparison with other countries’ estimates are challenging due to difference in surveillance case definitions, underlying characteristics of study-population, and methods used, influenza seems to be an important public health problem for Uganda. Further studies using population-based platforms to best characterize the impact of influenza disease burden in Uganda could help policy and stakeholders on resource allocations and interventions.
Our study had some important limitations. Firstly, as mentioned above, we used pneumonia to estimate hospitalizations associated with influenza and may thus have underestimated the true burden of disease. Influenza infections may result in exacerbations of underlying conditions such as asthma, diabetes, and other conditions which are not reflected in these analyses. Secondly, as we used the proportion of influenza positive SARI cases to estimate the fraction of influenza-associated pneumonia hospitalizations, we could have over or underestimated rates as SARI case-definition maybe different from that of pneumonia diagnosed based on clinician’s assessment of patient. Similarly, as pneumonia data were reported only for children <5 years and persons aged ≥5 years, the age distribution of SARI cases was used to define the finer age categories in the pneumonia data. The age-specific estimates of the true burden of influenza-associated pneumonia would vary by how well the SARI cases (identified in the influenza surveillance system) compared to the pneumonia cases (as identified by the healthcare workers at the health facilities). Thirdly, because of limited annual influenza testing by site and the age categories considered, one single proportion for the ages <2, 2–4, and ≥5 years (combining data from the three sites) was calculated and used to estimate the fraction of pneumonia that was associated with influenza. However, the potential effect of this on site-specific estimates may have been limited as exploratory analyses did not show important differences in influenza positivity by site. Lastly, this study did not consider the possible impact of HIV, and other known risk factors such as malnutrition, on pneumonia cases [6, 33]. Further analyses may be warranted not only to assess the extent to which these factors contribute the pneumonia burden in the study district, but also to facilitate extrapolation of burden of disease estimates to the other regions in Uganda.
Conclusions
Our findings expand knowledge of the impact of influenza infections and highlight a substantial burden of hospitalizations associated with influenza in children aged <5 years in Uganda. These findings suggest that young children, particularly those aged <2 years would benefit most from an annual influenza vaccination program.
Acknowledgments
The authors wish to thank staff at the sentinel sites who were involved in influenza surveillance work (samples and data collection) without whom this study would not have taken place. The authors also acknowledge the important role played by the Ministry of Health officials and the HMIS staff across the country, as well as healthcare workers who were involved in collecting data from all the health facilities in Wakiso, Mbarara and Tororo districts. We particularly thank Dr. Eddie Mukooyo, Assistant Commissioner of Health Services (Resource Center) who enabled us to access the HMIS data.
Funding: This study was supported by U.S. Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
References
- 1. Nair H, Brooks WA, Katz M, Roca A, Berkley JA, Madhi SA, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet. 2011;378(9807):1917–30. pmid:22078723.
- 2. Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2017. pmid:29248255.
- 3.
World Health Organization (WHO). Influenza fact sheet. http://www.who.int/mediacentre/factsheets/fs211/en/. Accessed on April 5th, 2018.
- 4.
World Health Organization (WHO). Influenza fact sheet. http://www.who.int/mediacentre/factsheets/fs211/en/. Accessed on May 17th, 2014. 2014.
- 5. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports / Centers for Disease Control. 2010;59(RR-8):1–62. pmid:20689501.
- 6. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86(5):408–16. pmid:18545744.
- 7. Gessner BD, Shindo N, Briand S. Seasonal influenza epidemiology in sub-Saharan Africa: a systematic review. Lancet Infect Dis. 2011;11(3):223–35. pmid:21371656.
- 8. Ortiz JR, Lafond KE, Wong TA, Uyeki TM. Pandemic influenza in Africa, lessons learned from 1968: a systematic review of the literature. Influenza Other Respir Viruses. 2012;6(1):11–24. pmid:21668669.
- 9. Tempia S, Walaza S, Moyes J, Cohen AL, von Mollendorf C, Treurnicht FK, et al. Risk Factors for Influenza-Associated Severe Acute Respiratory Illness Hospitalization in South Africa, 2012–2015. Open Forum Infect Dis. 2017;4(1):ofw262. pmid:28480255.
- 10. Emukule GO, Paget J, van der Velden K, Mott JA. Influenza-Associated Disease Burden in Kenya: A Systematic Review of Literature. PLoS One. 2015;10(9):e0138708. pmid:26398196.
- 11. Ntiri MP, Duque J, McMorrow ML, Frimpong JA, Parbie P, Badji E, et al. Incidence of medically attended influenza among residents of Shai-Osudoku and Ningo-Prampram Districts, Ghana, May 2013—April 2015. BMC Infect Dis. 2016;16(1):757. pmid:27964716.
- 12. Nyamusore J, Rukelibuga J, Mutagoma M, Muhire A, Kabanda A, Williams T, et al. The national burden of influenza-associated severe acute respiratory illness hospitalization in Rwanda, 2012–2014. Influenza Other Respir Viruses. 2018;12(1):38–45. pmid:29197152.
- 13. Theo A, Tempia S, Cohen AL, Simusika P, Chentulo E, Chikamukwa CM, et al. The national burden of influenza-associated severe acute respiratory illness hospitalization in Zambia, 2011–2014. Influenza Other Respir Viruses. 2018;12(1):46–53. pmid:29243406.
- 14. Rabarison JH, Tempia S, Harimanana A, Guillebaud J, Razanajatovo NH, Ratsitorahina M, et al. Burden and Epidemiology of Influenza- and Respiratory Syncytial Virus-Associated Severe Acute Respiratory Illness Hospitalization in Madagascar, 2011–2016. Influenza Other Respir Viruses. 2018. pmid:30152912.
- 15. Lutwama JJ, Bakamutumaho B, Kayiwa JT, Chiiza R, Namagambo B, Katz MA, et al. Clinic- and hospital-based sentinel influenza surveillance, Uganda 2007–2010. J Infect Dis. 2012;206 Suppl 1:S87–93. pmid:23169978.
- 16. Viboud C, Alonso WJ, Simonsen L. Influenza in tropical regions. PLoS medicine. 2006;3(4):e89. pmid:16509764.
- 17. Moura FE. Influenza in the tropics. Current opinion in infectious diseases. 2010;23(5):415–20. pmid:20644472.
- 18. Katz MA, Muthoka P, Emukule GO, Kalani R, Njuguna H, Waiboci LW, et al. Results from the first six years of national sentinel surveillance for influenza in Kenya, July 2007-June 2013. PLoS One. 2014;9(6):e98615. pmid:24955962.
- 19. Balinandi S, Bakamutumaho B, Kayiwa JT, Ongus J, Oundo J, Awor AC, et al. The viral aetiology of influenza-like illnesses in Kampala and Entebbe, Uganda, 2008. Afr J Lab Med. 2013;2(1):65. pmid:29043164 may have inappropriately influenced them in writing this article.
- 20. Yang W, Cummings MJ, Bakamutumaho B, Kayiwa J, Owor N, Namagambo B, et al. Transmission dynamics of influenza in two major cities of Uganda. Epidemics. 2018. pmid:29576517.
- 21. Yang W, Cummings MJ, Bakamutumaho B, Kayiwa J, Owor N, Namagambo B, et al. Dynamics of Influenza in Tropical Africa: Temperature, Humidity, and Co-circulating (sub)types. Influenza Other Respir Viruses. 2018. pmid:29573157.
- 22.
Uganda Bureau of Statistics (UBOS). The National Population and Housing Census 2014 –Main Report, Kampala, Uganda. https://unstats.un.org/unsd/demographic/sources/census/wphc/Uganda/UGA-2016-05-23.pdf. Accessed 2018 April 03. 2016.
- 23.
Uganda Ministry of Health. The Health management Information System. http://www.gou.go.ug/sites/default/files/media-files/THE%20HEALTH%20MANAGEMENT%20INFORMATION%20SYSTEM_0.pdf. Accessed on April 5th 2018.
- 24.
World Health Organization (WHO). Integrated management of childhood illness: caring for newborns and children in the community. Geneva: World Health Organization. http://www.who.int/iris/handle/10665/44398 2011.
- 25.
(UBOS) UBoS. Uganda National Household Survey 2012/2013. Kampala, Uganda. http://www.ubos.org/onlinefiles/uploads/ubos/UNHS_12_13/2012_13%20UNHS%20Final%20Report.pdf. Accessed 2018 April 03. 2014.
- 26. Makokha C, Mott J, Njuguna HN, Khagayi S, Verani JR, Nyawanda B, et al. Comparison of severe acute respiratory illness (sari) and clinical pneumonia case definitions for the detection of influenza virus infections among hospitalized patients, western Kenya, 2009–2013. Influenza Other Respir Viruses. 2016;10(4):333–9. Epub 2016/05/25. pmid:27219455.
- 27. Dawa JA, Chaves SS, Nyawanda B, Njuguna HN, Makokha C, Otieno NA, et al. National burden of hospitalized and non-hospitalized influenza-associated severe acute respiratory illness in Kenya, 2012–2014. Influenza Other Respir Viruses. 2017. pmid:29243402.
- 28. Lafond KE, Nair H, Rasooly MH, Valente F, Booy R, Rahman M, et al. Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982–2012: A Systematic Analysis. PLoS Med. 2016;13(3):e1001977. pmid:27011229 has participated on an influenza advisory board for Novartis. RB works with all major manufacturers of influenza vaccines in an advisory capacity, as a researcher on vaccines and as presenter of academic info at conferences, receiving support to travel and attend such conferences. The authors have declared that no other competing interests exist.
- 29. Centers for Disease Control and Prevention. Influenza Activity—United States, 2014–15 Season and Composition of the 2015–16 Influenza Vaccine, June 5, 2015 / 64(21);583–590. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6421a5.htm. Accessed on April 7th 2018.
- 30. Zhou H, Thompson WW, Viboud CG, Ringholz CM, Cheng PY, Steiner C, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clin Infect Dis. 2012;54(10):1427–36. pmid:22495079.
- 31. Dawood FS, Fiore A, Kamimoto L, Bramley A, Reingold A, Gershman K, et al. Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008. J Pediatr. 2010;157(5):808–14. pmid:20580018.
- 32. Campbell CN, Mytton OT, McLean EM, Rutter PD, Pebody RG, Sachedina N, et al. Hospitalization in two waves of pandemic influenza A(H1N1) in England. Epidemiol Infect. 2011;139(10):1560–9. pmid:21108872.
- 33. Iwuji CC, Mayanja BN, Weiss HA, Atuhumuza E, Hughes P, Maher D, et al. Morbidity in HIV-1-infected individuals before and after the introduction of antiretroviral therapy: a longitudinal study of a population-based cohort in Uganda. HIV medicine. 2011;12(9):553–61. pmid:21535347.